There is increased use of quadruple medical therapy among patients following implementation of an HF quality improvement initiative.

Madison Investments, an investment advisor, released its “Madison Sustainable Equity Strategy” first quarter 2025 investor ...

If Eli Lilly presents strong data, the stock could be set to rally and potentially be on a path to reaching new highs. Should ...

McDonald's stock was cut from buy to sell over a potential double-digit loss in sales due to weight-loss drugs.

United States Representative Gilbert Cisneros has executed a series of stock trades, with his picks in the defense sector ...

S&P 500, Eli Lilly and Company, Novo Nordisk A/S Class B, Novo Nordisk A/S. Read 's Market Analysis on Investing.com ...

The U.S. out of home (OOH) advertising industry posted its highest-ever Q1 revenue, reaching $1.98 billion, according to new ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

TD Cowen has lowered Eli Lilly’s price target from $1,050 to $960, but maintained a Buy rating, citing solid long-term ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...

The Gabelli Growth Fund (GABGX) returned (8.5)% during Q1 of 2025 vs. (10.0)% return for the Russell 1000 Growth Index. Click ...

TD Cowen analysts trimmed the price target for Eli Lilly and Company (NYSE:LLY) from $1,050 to $960, while reiterating a Buy ...